Male Breast Cancer: Understanding the Biology for Improved Patient Care

NCT01101425 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2026-05-12

No results posted yet for this study

Summary

Rationale: Gathering medical information and tumor samples from patients with male breast cancer may help doctors learn more about the disease.

Purpose retrospective part: to perform a large international retrospective analysis of clinical and biological data of male BC patients treated in the participating centers from 1990 to 2010.

Purpose prospective part: to create a registry of men with breast cancer for a period of 30 months (starting early 2014).

Conditions

Sponsors & Collaborators

  • Breast International Group

    collaborator OTHER
  • Swiss Cancer Institute

    collaborator OTHER
  • Cancer Trials Ireland

    collaborator NETWORK
  • Borstkanker Onderzoek Groep

    collaborator NETWORK
  • Swedish Association of Breast Oncologists

    collaborator UNKNOWN
  • Hellenic Cooperative Oncology Group

    collaborator OTHER
  • Hellenic Oncology Research Group

    collaborator OTHER
  • Latin American Cooperative Oncology Group

    collaborator OTHER
  • Translational Breast Cancer Research Consortium

    collaborator OTHER
  • European Organisation for Research and Treatment of Cancer - EORTC

    lead NETWORK

Principal Investigators

  • Fatima Cardoso, MD · Champalimaud Cancer Center (Portugal)

  • Sharon H. Giordano, MD, MPH · M. D. Anderson Cancer Center (TX, USA)

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-12-31
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States
  • Belgium
  • Brazil
  • Egypt
  • Greece
  • Ireland
  • Mexico
  • Netherlands
  • Peru
  • Poland
  • Portugal
  • Serbia
  • Spain
  • Sweden
  • Switzerland
  • United Kingdom

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01101425 on ClinicalTrials.gov